Apoptosis induced by NS1 gene of Canine Parvovirus-2 is caspase dependent and p53 independent

Virus Research

Volumn 173, Issue 2, 2013, Pages 426-430

  Saxena, Lovleen ^a   Kumar, G Ravi ^a   Saxena, Shikha ^a   Chaturvedi, Uttara ^a   Sahoo, Aditya Prasad ^a   Singh, Lakshya Veer ^a   Santra, Lakshman ^a   Palia, S K ^a   Desai, G S ^a   Tiwari, A K ^a  

^a INDIAN VETERINARY RESEARCH INSTITUTE   (India)

Author keywords

Apoptosis; Caspase 3; CPV2; NS1; P53

Indexed keywords

CASPASE 3; NONSTRUCTURAL PROTEIN 1; PHOSPHATIDYLSERINE; PROTEIN P53;

APOPTOSIS; ARTICLE; CELL COUNT; CONTROLLED STUDY; DIPLOIDY; DNA FRAGMENTATION; ENZYME ACTIVATION; ENZYME ACTIVITY; FELINE PANLEUKOPENIA VIRUS; FEMALE; GENE TRANSLOCATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

APOPTOSIS; CASPASE 3; DNA FRAGMENTATION; EPITHELIAL CELLS; HELA CELLS; HUMANS; PARVOVIRUS, CANINE; PHOSPHATIDYLSERINES; TUMOR SUPPRESSOR PROTEIN P53; VIRAL NONSTRUCTURAL PROTEINS; VIRULENCE FACTORS;

CANINE PARVOVIRUS 2; CANIS FAMILIARIS; METAZOA; PARVOVIRUS;

EID: 84876865681     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2013.01.020     Document Type: Article

References (35)

1. Adams J.M., Cory S. Bcl-2-regulated apoptosis: mechanism and therapeutic potential. Current Opinion in Immunology 2007, 19(5):488-496.
2. Chen A.Y., Zhang E.Y., Guan W., Cheng F., Kleiboeker S., Yankee T.M., Qiu J. The small 11 kDa nonstructural protein of human parvovirus B19 plays a key role in inducing apoptosis during B19 virus infection of primary erythroid progenitor cells. Blood 2010, 115(5):1070-1080.
3. Decaro N., Buonavoglia C. Canine parvovirus - a review of epidemiological and diagnostic aspects, with emphasis on type 2c. Veterinary Microbiology 2012, 155(1):1-12.
4. Efeyan A., Serrano M. p53: guardian of the genome and policeman of the oncogenes. Cell Cycle 2007, 6(9):1006-1010.
5. Everts B., van der Poel H.G. Replication-selective oncolytic viruses in the treatment of cancer. Cancer Gene Therapy 2005, 12(2):141-161.
6. Fraker P.J., King L.E., Lill-Elghanian D., Telford W.G. Quantification of apoptotic events in pure and heterogeneous populations of cells using the flow cytometer. Methods in Cell Biology 1995, 46:57-76.
7. Gilbert L., Valilehto O., Kirjavainen S., Tikka P.J., Mellett M., Kapyla P., Oker-Blom C., Vuento M. Expression and subcellular targeting of canine parvovirus capsid proteins in baculovirus-transduced NLFK cells. FEBS Letters 2005, 579(2):385-392.
8. Giorgi C., Wieckowski M.R., Pandolfi P.P., Pinton P. Mitochondria associated membranes (MAMs) as critical hubs for apoptosis. Communicative and Integrative Biology 2011, 4(3):334-335.
9. Goldstein I., Marcel V., Olivier M., Oren M., Rotter V., Hainaut P. Understanding wild-type and mutant p53 activities in human cancer: new landmarks on the way to targeted therapies. Cancer Gene Therapy 2011, 18(1):2-11.
10. Hristov G., Kramer M., Li J., El-Andaloussi N., Mora R., Daeffler L., Zentgraf H., Rommelaere J., Marchini A. Through its nonstructural protein NS1, parvovirus H-1 induces apoptosis via accumulation of reactive oxygen species. Journal of Virology 2010, 84(12):5909-5922.
11. Huang C., Ma W.Y., Li J., Dong Z. Arsenic induces apoptosis through a c-Jun NH2-terminal kinase-dependent, p53-independent pathway. Cancer Research 1999, 59(13):3053-3058.
12. Iseki H., Shimizukawa R., Sugiyama F., Kunita S., Iwama A., Onodera M., Nakauchi H., Yagami K. Parvovirus nonstructural proteins induce an epigenetic modification through histone acetylation in host genes and revert tumor malignancy to benignancy. Journal of Virology 2005, 79(14):8886-8893.
13. Johnson K.R., Fan W. Reduced expression of p53 and p21WAF1/CIP1 sensitizes human breast cancer cells to paclitaxel and its combination with 5-fluorouracil. Anticancer Research 2002, 22(6A):3197-3204.
14. Kerr J.F., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. British Journal of Cancer 1972, 26(4):239-257.
15. Kumar G.R., Saxena S., Saxena L., Chaturvedi U., Santra L., Kumar R., Sahoo A.P., Rajmani, Kumar A., Desai G.S., Kumar S., Tiwari A.K. In vitro expression studies of non structural 1 protein of Canine Parvo virus 2 by polyclonal antiserum raised against CPV2-NS1 protein expressed in Escherichia coli as an antigen. Indian Journal of Experimental Biology 2012, 50(9):618-624.
16. Kumar R., Tiwari A.K., Chaturvedi U., Kumar G.R., Sahoo A.P., Rajmani R.S., Saxena L., Saxena S., Tiwari S., Kumar S. Velogenic newcastle disease virus as an oncolytic virotherapeutics: in vitro characterization. Applied Biochemistry and Biotechnology 2012, 167(7):2005-2022.
17. Marsden V.S., O'Connor L., O'Reilly L.A., Silke J., Metcalf D., Ekert P.G., Huang D.C., Cecconi F., Kuida K., Tomaselli K.J., Roy S., Nicholson D.W., Vaux D.L., Bouillet P., Adams J.M., Strasser A. Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome. Nature 2002, 419(6907):634-637.
18. Moffatt S., Tanaka N., Tada K., Nose M., Nakamura M., Muraoka O., Hirano T., Sugamura K. A cytotoxic nonstructural protein, NS1, of human parvovirus B19 induces activation of interleukin-6 gene expression. Journal of Virology 1996, 70(12):8485-8491.
19. Morita S., Shimanouchi T., Sasaki M., Umakoshi H., Kuboi R. Detection of a heat stress-mediated interaction between protein and phospholipid membrane using dielectric measurement. Journal of Bioscience and Bioengineering 2003, 95(3):252-256.
20. Nicholson D.W., Ali A., Thornberry N.A., Vaillancourt J.P., Ding C.K., Gallant M., Gareau Y., Griffin P.R., Labelle M., Lazebnik Y.A., et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995, 376(6535):37-43.
21. Nuesch J.P., Rommelaere J. A viral adaptor protein modulating casein kinase II activity induces cytopathic effects in permissive cells. Proceedings of the National Academy of Sciences of the United States of America 2007, 104(30):12482-12487.
22. Nykky J., Tuusa J.E., Kirjavainen S., Vuento M., Gilbert L. Mechanisms of cell death in canine parvovirus-infected cells provide intuitive insights to developing nanotools for medicine. International Journal of Nanomedicine 2010, 5:417-428.
23. Op De Beeck A., Sobczak-Thepot J., Sirma H., Bourgain F., Brechot C., Caillet-Fauquet P. NS1- and minute virus of mice-induced cell cycle arrest: involvement of p53 and p21(cip1). Journal of Virology 2001, 75(22):11071-11078.
24. Poole B.D., Karetnyi Y.V., Naides S.J. Parvovirus B19-induced apoptosis of hepatocytes. Journal of Virology 2004, 78(14):7775-7783.
25. Poole B.D., Zhou J., Grote A., Schiffenbauer A., Naides S.J. Apoptosis of liver-derived cells induced by parvovirus B19 nonstructural protein. Journal of Virology 2006, 80(8):4114-4121.
26. Porter A.G., Janicke R.U. Emerging roles of caspase-3 in apoptosis. Cell Death and Differentiation 1999, 6(2):99-104.
27. Ravindra P.V., Tiwari A.K., Ratta B., Bais M.V., Chaturvedi U., Palia S.K., Sharma B., Chauhan R.S. Time course of Newcastle disease virus-induced apoptotic pathways. Virus Research 2009, 144(1-2):350-354.
28. Ravindra P.V., Tiwari A.K., Sharma B., Chauhan R.S. Newcastle disease virus as an oncolytic agent. Indian Journal of Medical Research 2009, 130(5):507-513.
29. Saxena L., Chaturvedi U., Saxena S., Kumar G.R., Sahoo A.P., Kumar S., Doley J., Rajmani R.S., Singh P.K., Kumar R., Tiwari A.K. Characterization and in vitro expression of non-structural 1 protein of canine parvovirus (CPV-2) in mammalian cell line. Indian Journal of Experimental Biology 2011, 49(9):654-659.
30. Schmittgen T.D., Livak K.J. Analyzing real-time PCR data by the comparative C(T) method. Nature Protocols 2008, 3(6):1101-1108.
31. Singh P.K., Doley J., Kumar G.R., Sahoo A.P., Tiwari A.K. Oncolytic viruses & their specific targeting to tumour cells. Indian Journal of Medical Research 2012, 136(4):571-584.
32. Tomek M., Akiyama T., Dass C.R. Role of Bcl-2 in tumour cell survival and implications for pharmacotherapy. Journal of Pharmacy and Pharmacology 2012, 64(12):1695-1702.
33. Tomek S., Horak P., Pribill I., Haller G., Rossler M., Zielinski C.C., Pils D., Krainer M. Resistance to TRAIL-induced apoptosis in ovarian cancer cell lines is overcome by co-treatment with cytotoxic drugs. Gynecologic Oncology 2004, 94(1):107-114.
34. Vukosavic S., Stefanis L., Jackson-Lewis V., Guegan C., Romero N., Chen C., Dubois-Dauphin M., Przedborski S. Delaying caspase activation by Bcl-2: A clue to disease retardation in a transgenic mouse model of amyotrophic lateral sclerosis. Journal of Neuroscience 2000, 20(24):9119-9125.
35. Wyllie A.H., Kerr J.F., Currie A.R. Cell death: the significance of apoptosis. International Review of Cytology 1980, 68:251-306.